Trials / Completed
CompletedNCT07008274
Laparoscopic Sleeve Gastrectomy-Induced Decline in Plasma Asprosin and Its Association With Metabolic Recovery
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 85 (actual)
- Sponsor
- Northern Jiangsu People's Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
the present study aimed to systematically assess the changes in plasma asprosin levels at 3, 6, and 12 months after LSG, to explore the relationships between asprosin dynamics and key metabolic parameters, including body mass index (BMI), fasting glucose, insulin resistance assessed by the homeostasis model (HOMA-IR), and lipid profiles, and to compare asprosin concentrations between bariatric patients and healthy normal-weight controls.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | surgery | laparoscopic sleeve gastrectomy |
Timeline
- Start date
- 2021-01-01
- Primary completion
- 2025-01-31
- Completion
- 2025-01-31
- First posted
- 2025-06-06
- Last updated
- 2025-06-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07008274. Inclusion in this directory is not an endorsement.